& Butcher, J
The Medicare GLP-1 Bridge (live since July 1, 2026) covers all Wegovy formulations for weight loss at $50/month for eligible Part D beneficiariesno CV diagnosis required, just the BMI-based eligibility criteria and prescriber prior authorization
KG: Yeah, so the legislators who originally passed this law in 2023 are seeking to pass a law, again, that specifies coverage of GLP-1S for people who have a BMI of 35 or higher, and it would also guarantee continued coverage if those people were to lose weight fall below that BMI, as long as a doctor says, hey, if, if this person were to go off of this drug, they would likely regain the weight
But the study also made it clear: theres still not enough solid clinical evidence to back it up
Our Ozempic litigation experience means we can effectively represent your interests alongside hundreds of other plaintiffs while ensuring your individual story receives the attention it deserves
These typically present as redness, swelling, or itching at the injection site and usually resolve within 25 days without treatment
